Reusable Core Biopsy Instrument Market Report 2026

Reusable Core Biopsy Instrument Market Overview

• Reusable Core Biopsy Instrument market size has reached to $1.03 billion in 2025 • Expected to grow to $1.62 billion in 2030 at a compound annual growth rate (CAGR) of 9.5% • Growth Driver: Increasing Incidence Of Cancer And Chronic Diseases Fueling The Market Growth Due To Rising Adoption Of Early And Accurate Diagnostic Procedures • Market Trend: Advancement Of Integrated And Precision-Controlled Biopsy Systems • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Reusable Core Biopsy Instrument Market?

A reusable core biopsy instrument is a medical device designed to obtain a cylindrical tissue sample from the body for diagnostic examination. It is built for repeated use after sterilization, ensuring durability and precision in tissue sampling procedures. A reusable core biopsy instrument helps maintain consistent sample quality while supporting cost-effective clinical workflows over time. The main product types of reusable core biopsy instrument include reusable core biopsy needles, reusable biopsy guns, reusable automated biopsy instruments, and reusable semi automated biopsy instruments. Reusable core biopsy needles refer to sterilizable medical instruments designed to repeatedly obtain core tissue samples for histopathological examination while maintaining consistent sampling performance across multiple procedures. These instruments support ultrasound guided biopsy, computed tomography guided biopsy, magnetic resonance imaging guided biopsy, stereotactic guided biopsy, and other procedure guidances and are available as spring loaded automated biopsy instruments, vacuum assisted reusable biopsy devices, manual core biopsy instruments, and pneumatic driven biopsy instruments. The various applications involved are breast biopsy, prostate biopsy, lung biopsy, liver biopsy, kidney biopsy, bone and bone marrow biopsy, soft tissue biopsy, and others, and they are used by several end users such as hospitals, diagnostic centers, specialty clinics, ambulatory surgical centers, and academic and research institutes.

What Is The Reusable Core Biopsy Instrument Market Growth Forecast?

The reusable core biopsy instrument market size is expected to see strong growth in the next few years. It will grow to $1.62 billion in 2030 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to growing demand for advanced tissue sampling procedures, increasing focus on sustainable reusable healthcare devices, rising adoption of precision biopsy workflows, expanding diagnostic screening programs, increasing demand for durable and high performance biopsy instruments. Major trends in the forecast period include increasing adoption of reusable precision biopsy instruments, growing demand for cost efficient tissue sampling solutions, rising focus on enhanced sterilization and device longevity, increasing preference for consistent diagnostic sample quality, expansion of minimally invasive biopsy procedures.

What Are The Drivers Of The Reusable Core Biopsy Instrument Market?

The rising incidence of cancer and chronic diseases is expected to propel the growth of the reusable core biopsy instrument market going forward. Cancer is a disease in which abnormal cells grow uncontrollably and can spread in the body, while chronic diseases are long-lasting health conditions that progress slowly and require ongoing management. Cancer and chronic diseases are increasing mainly due to unhealthy lifestyles, which include poor diet, lack of physical activity, smoking, and alcohol consumption that gradually harm the body over time. Reusable core biopsy instruments help in cancer and chronic diseases by enabling precise tissue sampling for accurate diagnosis, allowing doctors to identify disease type and stage early and guide appropriate treatment decisions. For instance, in April 2025, according to the Centers for Disease Control and Prevention (CDC), a US-based federal agency, in 2023, approximately 194 million U.S. adults, or 76.4%, reported having at least one chronic condition. Therefore, the rising incidence of cancer and chronic diseases is driving the growth of the reusable core biopsy instrument industry. The growth in minimally invasive procedures is expected to propel the growth of the reusable core biopsy instrument market going forward. Minimally invasive procedures are medical treatments that use small incisions or natural openings with specialized tools to reduce tissue damage, pain, and recovery time compared to open surgery. Minimally invasive procedures are increasing as patients prefer faster recovery, reduced pain, and shorter hospital stays, while healthcare systems benefit from lower overall treatment costs and improved efficiency. Reusable core biopsy instruments support minimally invasive procedures by enabling doctors to obtain accurate tissue samples through small incisions with high precision, reducing the need for open surgical methods and helping minimize patient trauma and recovery time. For instance, in June 2024, according to the American Society of Plastic Surgeons, a US-based organization, in 2023, minimally invasive procedures rose by 7% compared to the previous year. Therefore, the growth in minimally invasive procedures is driving the growth of the reusable core biopsy instrument industry.

Key Players In The Global Reusable Core Biopsy Instrument Market

Major companies operating in the reusable core biopsy instrument market are Becton Dickinson and Company (BD), Cook Group Inc. / Cook Medical, Argon Medical Devices Inc., STERYLAB S.r.l., MDL S.r.l., BIP Medical S.r.l. / BIP GmbH, UROMED Kurt Drews GmbH, GEOTEK MEDICAL, Biomedical Srl, Iscon Surgicals Ltd., Chamfond Biotech Co. Ltd., Vigeo S.r.l., Histo S.r.l., SteryMed S.r.l., Advin Health Care, Meditech Devices Pvt. Ltd., Matek Medical, Adria Medical

Global Reusable Core Biopsy Instrument Market Trends and Insights

Major companies operating in the reusable core biopsy instrument market are increasingly prioritizing integrated biopsy systems with adjustable actuation and precision tissue-sampling capabilities to improve biopsy accuracy, preserve tissue integrity, and support reliable pathological diagnosis. These systems combine reusable actuator instruments with biopsy needles designed to obtain full-length, unbroken tissue cores, enabling clinicians to collect representative samples while controlling sampling depth and reducing the risk of under- or overshooting the target. For instance, in January 2025, Triopsy Medical, Inc., a US-based medical device company, received FDA 510(k) clearance for its Triopsy Integrated Biopsy System, comprising the Triopsy Actuator and Triopsy Biopsy Needle. The FDA classified the device as a gastroenterology-urology biopsy instrument, and the cleared system uses a reusable actuator with a disposable biopsy needle for prostate tissue sampling. The needle incorporates patented ridges designed to hold and protect the tissue sample, while the actuator provides variable sample lengths for different prostate biopsy locations. It is combining a reusable actuation platform with precision tissue-sampling technology, the Triopsy system supports more controlled prostate biopsies and aims to improve the quality and integrity of tissue cores used for pathological assessment.

What Defines the Reusable Core Biopsy Instrument Market?

The reusable core biopsy instrument market consists of sales of reusable biopsy introducer sets, reusable tissue sampling cannulas, and reusable biopsy guide systems. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Reusable Core Biopsy Instrument Market Report 2026?

The reusable core biopsy instrument market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the reusable core biopsy instrument industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.